DIONNE HARRISON: Open Payments
NPI 1578755922 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 51 payments from 9 companies in 2025. Trend: 2023 $1,237 · 2024 $1,284 · 2025 $1,005
Food & beverage: $1,005
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 17 | $293 |
| Indivior Inc. | 6 | $244 |
| Neurocrine BioSciences, Inc. | 15 | $225 |
| Alkermes, Inc. | 4 | $74 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| ABBVIE INC. | 2 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: SUBLOCADE, HETLIOZ, INGREZZA, FANAPT, COBENFY, VIVITROL, ARISTADA, INVEGA SUSTENNA.
Industry payments across NC — which companies pay providers there.
